BARDA’s RRPV RFI on NMJ Micro-Physiological Systems for BoNT Evaluation
RRPV_RFI_BoNT-NMJ RFI Final Post Overview of Solicitation The Rapid Response Partnership Vehicle (RRPV), on behalf of the Biomedical Advanced Research and Development Authority (BARDA), has released a Request for Information (RFI) focused on neuromuscular junction (NMJ) micro-physiological systems (MPS) for botulinum neurotoxin (BoNT) applications. Managed by Advanced Technology International (ATI), this RFI seeks to assess […]
BARDA’s RRPV RFI on NMJ Micro-Physiological Systems for BoNT Evaluation Read More »